ESPR - Esperion Therapeutics Fri 13'th Jan 2017
Stock analysis for Fri 13'th Jan 2017 (Updated daily)
Sell candidate since 2017-01-11
Esperion Therapeutics Stock Analysis
Esperion Therapeutics fell by -1.72% in the last day, from USD 12.21 to USD 12.00. , and has now fallen 5 day in a row The price has fallen in 6 of the last 10 days and is down by -5.51% for this period. Volume increased in the last day by 55 076 shares, but on falling prices. This is may be an early warning and risk is increased slightly for the next couple of days. In total there were 286 035 shares were bought and sold for approximately USD 3.43 million.
Esperion Therapeutics lays in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 17.6% during the next 3 months and, with 90% probability will hold a price between USD 13.03 and USD 17.06 at the end of this period.
There are few to none technical positive signals at the moment. Esperion Therapeutics holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at USD 13.12 and USD 12.38. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Monday January 09, 2017, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSI14 is 44 and the stock is currently not being overbought or oversold
Support & Resistance
Esperion Therapeutics finds support from accumulated volume at USD 11.51, USD 11.00, and USD 9.92. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 12.05, USD 12.70 and USD 13.84.
The stock is about to test the resistance from accumulated volume at USD 12.05 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved USD 0.69 between high and low, or 5.82%. For the last week, the stock has had a daily average volatility of 6.14%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
The stock holds several negative signals and despite the positive trend we believe Esperion Therapeutics to perform weak in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.